Shandong builds a 'blue drug store', the world's largest alginate production
The reporter learned from the "Thirteenth Five-Year" Achievement Tour Series press conference held by the Shandong Provincial Government Information Office on the afternoon of November 30 that Shandong has built a "blue drug store" and has the world's largest alginate production capacity.
Zhang Jiandong, a member of the Party Leadership Group of the Shandong Provincial Department of Natural Resources and Director of the Provincial Oceanic Bureau, introduced that the marine biomedical industry is one of the most potential strategic emerging industries in my country, and its compound growth rate is twice the growth rate of marine GDP. Shandong is a major province in the marine biopharmaceutical industry, with an output value of more than 20 billion yuan, accounting for about half of the country's total. During the "13th Five-Year Plan" period, Shandong has increased its efforts in research and development of marine innovative drugs, established the "China Blue Drug Bank Development Fund" with a total scale of 5 billion yuan, and established the Shandong Provincial Marine Drug Manufacturing Innovation Center. The "Blue Medicine Bank" has built six product development platforms including modern marine medicine and modern marine Chinese medicine. The domestically-made new drug GV971 for Alzheimer's disease independently developed by the academician Guan Huashi's team was approved for marketing, becoming the world's 14th (China's second) marine drug; the "Blue Drug Library" key new drug project, the anti-tumor drug BG136, is about to be launched Clinical declaration. Qingdao City has built the world's largest seaweed biological product industrial base, with the world's largest alginate production capacity; Zhenghaier Pharmaceutical is the only national marine drug pilot plant in China; Yantai Dongcheng Pharmaceutical has become the world's largest chondroitin sulfate raw material Manufacturer, the only domestic supplier of chondroitin sulfate injections.
Zhang Jiandong said that at a new starting point, he will continue to gather the majestic forces of the construction of a strong marine province, cut the waves and map the sea, strive to create a new situation in the construction of a strong marine province, and make Shandong's contribution to the construction of a strong marine country!
Looking for chemical products? Let suppliers reach out to you!
2026-07-01
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
From API China to the Global Pharmaceutical Chain: ECHEMI Is Reshaping the "New Speed" of Pharmaceutical Trade
-
Review of the 93rd API China: In Chongqing, Witnessing the Global Pulse of the Pharmaceutical Industry
-
On the Second Day of the 93rd API China: ECHEMI Advances Global Dialogue in the Pharmaceutical Industry Through Innovative Practices
-
CPHI China 2026 Concludes Successfully, ECHEMI Serves Global Pharmaceutical Clients
-
72 Hours at API China: Where China’s API Export Industry Is Heading Next
-
ECHEMI WPO and Pharmaceutical Division Showcase Dual Strengths at the 94th API China, Tackling Pharmaceutical Export Challenges with Precision
-
Understand the New Rules to Enter the Market | ECHEMI × API China 2026 Overseas Pharmaceutical Market & Product Trends Conference Successfully Concluded
-
When Global Buyers Sit at the Same Table, Chinese Suppliers Respond: A Real 1-on-1 Online Business Matching Event
-
When Global Buyers No Longer Visit Trade Shows but “Select Suppliers with a Click”
-
ECHEMI and CPHI China Jointly Host Pharmaceutical Business Match-making Event
Recommend Reading
-
Styrene-butadiene rubber market prices fluctuate and rise sharply
-
Weak Demand: Melamine Market Pressured Amid Challenges
-
Cost Support: Styrene-butadiene rubber market prices rise sharply
-
Unilever Sells Kate Somerville Brand to Rare Beauty Brands
-
Demand Continues to Weaken, China's Acrylonitrile Market Fluctuates Downward